126 related articles for article (PubMed ID: 34962825)
1. Rhomboid domain containing 1 promotes the growth of non-small cell lung cancer through the activation of EGFR and regulation of the BIK-mediated apoptosis.
Xu ZY; Li X; Yao RH; Yang LM; Peng H; Ren WJ; Lu H; Wang P
Neoplasma; 2022 Mar; 69(2):311-320. PubMed ID: 34962825
[TBL] [Abstract][Full Text] [Related]
2. RHBDD1 silencing inhibited cell growth and invasion of non-small cell lung cancer by mediating ZEB1/PI3K/AKT signaling pathway.
Xu Z; Wang R; Li X; Yang L; Peng H; Wang Y; Wang P
J Mol Histol; 2021 Jun; 52(3):503-510. PubMed ID: 33515112
[TBL] [Abstract][Full Text] [Related]
3. miR-145-5p restrained cell growth, invasion, migration and tumorigenesis via modulating RHBDD1 in colorectal cancer via the EGFR-associated signaling pathway.
Niu Y; Zhang J; Tong Y; Li J; Liu B
Int J Biochem Cell Biol; 2019 Dec; 117():105641. PubMed ID: 31693935
[TBL] [Abstract][Full Text] [Related]
4. RHBDD1 promotes proliferation, migration, invasion and EMT in renal cell carcinoma via the EGFR/AKT signaling pathway.
Li M; Cai L; Wang X; Yu Y; Jian W; Bao G; Gao Z; Guo J; Zhang J; Li C; Zhang C
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34581421
[TBL] [Abstract][Full Text] [Related]
5. Rhomboid domain-containing protein 1 promotes breast cancer progression by regulating the p-Akt and CDK2 levels.
Zhang X; Zhao Y; Wang C; Ju H; Liu W; Zhang X; Miao S; Wang L; Sun Q; Song W
Cell Commun Signal; 2018 Oct; 16(1):65. PubMed ID: 30286765
[TBL] [Abstract][Full Text] [Related]
6. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
7. Silibinin suppresses epithelial-mesenchymal transition in human non-small cell lung cancer cells by restraining RHBDD1.
Xu S; Zhang H; Wang A; Ma Y; Gan Y; Li G
Cell Mol Biol Lett; 2020; 25():36. PubMed ID: 32528541
[TBL] [Abstract][Full Text] [Related]
8. A novel member of the Rhomboid family, RHBDD1, regulates BIK-mediated apoptosis.
Wang Y; Guan X; Fok KL; Li S; Zhang X; Miao S; Zong S; Koide SS; Chan HC; Wang L
Cell Mol Life Sci; 2008 Nov; 65(23):3822-9. PubMed ID: 18953687
[TBL] [Abstract][Full Text] [Related]
9. Aldolase A promotes proliferation and G
Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral vector mediated delivery of RHBDD1 shRNA down regulated the proliferation of human glioblastoma cells.
Wei X; Lv T; Chen D; Guan J
Technol Cancer Res Treat; 2014 Feb; 13(1):87-93. PubMed ID: 23883433
[TBL] [Abstract][Full Text] [Related]
11. MiR-924 as a tumor suppressor inhibits non-small cell lung cancer by inhibiting RHBDD1/Wnt/β-catenin signaling pathway.
Wang H; Chen X; Yang B; Xia Z; Chen Q
Cancer Cell Int; 2020; 20():491. PubMed ID: 33041671
[TBL] [Abstract][Full Text] [Related]
12. FoxO3a inhibiting expression of EPS8 to prevent progression of NSCLC: A new negative loop of EGFR signaling.
Wen Q; Jiao X; Kuang F; Hou B; Zhu Y; Guo W; Sun G; Ba Y; Yu D; Wang D; Zhang F; Qiao HC; Wang S; Tang S; Qiao H
EBioMedicine; 2019 Feb; 40():198-209. PubMed ID: 30738830
[TBL] [Abstract][Full Text] [Related]
13. Oncoprotein HBXIP promotes tumorigenesis through MAPK/ERK pathway activation in non-small cell lung cancer.
Zhang J; Sun B; Ruan X; Hou X; Zhi J; Meng X; Zheng X; Gao M
Cancer Biol Med; 2021 Feb; 18(1):105-119. PubMed ID: 33628588
[TBL] [Abstract][Full Text] [Related]
14. Calpain-2 Enhances Non-Small Cell Lung Cancer Progression and Chemoresistance to Paclitaxel via EGFR-pAKT Pathway.
Xu F; Gu J; Lu C; Mao W; Wang L; Zhu Q; Liu Z; Chu Y; Liu R; Ge D
Int J Biol Sci; 2019; 15(1):127-137. PubMed ID: 30662353
[TBL] [Abstract][Full Text] [Related]
15. PLAUR Confers Resistance to Gefitinib Through EGFR/P-AKT/Survivin Signaling Pathway.
Zhou J; Kwak KJ; Wu Z; Yang D; Li J; Chang M; Song Y; Zeng H; Lee LJ; Hu J; Bai C
Cell Physiol Biochem; 2018; 47(5):1909-1924. PubMed ID: 29961070
[TBL] [Abstract][Full Text] [Related]
16. The long non-coding RNA PVT1/miR-145-5p/ITGB8 axis regulates cell proliferation, apoptosis, migration and invasion in non-small cell lung cancer cells.
Wei CM; Zhao XF; Qiu HB; Ming Z; Liu K; Yan J
Neoplasma; 2020 Jul; 67(4):802-812. PubMed ID: 32202906
[TBL] [Abstract][Full Text] [Related]
17. LncRNA HULC promotes non-small cell lung cancer cell proliferation and inhibits the apoptosis by up-regulating sphingosine kinase 1 (SPHK1) and its downstream PI3K/Akt pathway.
Liu L; Zhou XY; Zhang JQ; Wang GG; He J; Chen YY; Huang C; Li L; Li SQ
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8722-8730. PubMed ID: 30575912
[TBL] [Abstract][Full Text] [Related]
18. Rhomboid domain containing 1 promotes colorectal cancer growth through activation of the EGFR signalling pathway.
Song W; Liu W; Zhao H; Li S; Guan X; Ying J; Zhang Y; Miao F; Zhang M; Ren X; Li X; Wu F; Zhao Y; Tian Y; Wu W; Fu J; Liang J; Wu W; Liu C; Yu J; Zong S; Miao S; Zhang X; Wang L
Nat Commun; 2015 Aug; 6():8022. PubMed ID: 26300397
[TBL] [Abstract][Full Text] [Related]
19. Acetyl-11-keto-β-boswellic acid enhances the cisplatin sensitivity of non-small cell lung cancer cells through cell cycle arrest, apoptosis induction, and autophagy suppression via p21-dependent signaling pathway.
Lv M; Zhuang X; Zhang Q; Cheng Y; Wu D; Wang X; Qiao T
Cell Biol Toxicol; 2021 Apr; 37(2):209-228. PubMed ID: 32562082
[TBL] [Abstract][Full Text] [Related]
20. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1.
Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W
J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
